Search results

Theory-organized: Model Introspection Self-organizing: General Population Model Performance That best model only had a sensitivity of 0.45 and specificity of 0.82. They noted that simple regression models performed no better than chance.

Could be useful to have a look to see what they measured with respect to fatigue. The authors seem quite positive about the capacity for measures to predict fatigue.

From Supplementary Data 1 - the exclusion criteria made it less likely for the ME/CFS participants to have a psychiatric history: So, I wouldn't use the Walitt et al study as evidence of psychiatric illness not being a risk factor for ME/CFS. But there certainly are others, including the...

Gosh, that was a roller coaster. Good, bad, ugly, confused... This Professor H. Prüß, what role does he have in the fatigue guideline he talks about, and how influential will it be?

3.4 Differences in Hypothalamus Connectivity Between ME/CFS and Controls So strength of connectivity wasn't different. Reported confidence intervals for relationships of connectivity degree (as opposed to strength, whatever 'degree' means) straddle either side of zero. So, I don't think they...

Brain imaging results are all over the place across various studies, as noted in the introduction of this paper. It's not clear to me how much of the analysis was automated and how much involved manual work that might be subject to bias. There was no statement about the people analysing the...

It's not bad on this thread, for the reason MrMagoo notes :), but we have converted an existing thread into a place for wearables news: News on wearable technologies for research and have copied Binkie4's post there.

We have a number of threads about the underlying study: MSS3 See here Effectiveness of a symptom-clinic intervention ... multiple and persistent physical symptoms, 2024, Burton, Deary et al There are links to the other threads there. MSS3: a morass of mediocrity.

A QALY is a year of life lived in perfect health. The mean QALY difference was 0.0447. I make that 16 days. It is set up to be a one-off intervention. And, as @rvallee says, actually as the paper says, the difference was not statistically significant. So, a tiny absolute difference that...

Even as Cochrane falls to bits in some places, seemingly unable to effectively deal with complaints, the Larun et al review is still there causing problems. Cochrane Australia is based at Monash University. There's a contact in Austria - maybe someone active in the We&ME Foundation would have...

https://www.cochrane.org/about-us/our-global-community/geographic-groups Looks like there are contacts for a lot of countries including the UK.

I've been regularly sending similar emails to the Cochrane contact person for my country - e.g. petition updates and links to the petition. If you (the S4ME members) have the capacity to do so, you could find out who the Cochrane contact person for your country is, and contact them. At the...

Yes, me too. Thank you to Chris and Simon, and everyone who stands with us, even though it is not the easy road.

I've adjusted the thread's title.

Re ME/CFS is one group or multiple groups: I don't understand why people who are generally (and rightly) very skeptical of ME/CFS research findings don't apply the same skepticism to the 'twin peaks' incidence idea. The evidence for that idea is very thin.

Moderators have created a new thread: What needs to change to ensure better care for people with ME/CFS with feeding difficulties? for discussion about the policy and implementation environment that continues to influence management of feeding difficulties in people with ME/CFS. There will...

That's a useful summary. To some extent, we don't have to know for sure what went on in Maeve's case. If there is clinical guidance that is likely to be interpreted as making various forms of assisted nutrition off limits for people assessed by the treating clinicians as having 'functional...

Just on the 'trial report' prefix, a response from the moderation team: The trial report prefix is used for interventional studies, so, where a treatment has been trialled. It is fine to have no prefix, plenty of papers don't need a prefix. We understand that there is a grey area, where the...

Thanks for your replies @Jonathan Edwards and your ongoing work. Just as a side point on sectioning and capacity for decision making (sorry, taking the thread further off-topic): Practice varies, I don't think it is a big deal for some doctors. Having spent a lot of the last year sitting with...